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NOMe-seqDNAmethylation and nucleosome positioning are two keymechanisms that contribute to the epigenetic control
of gene expression. During carcinogenesis, the expression of many genes is altered alongside extensive changes
in the epigenome, with repressed genes often being associated with local DNA hypermethylation and gain of
nucleosomes at their promoters. However the spectrum of alterations that occur at distal regulatory regions
has not been extensively studied. To address this we used Nucleosome Occupancy and Methylation sequencing
(NOMe-seq) to compare the genome-wide DNA methylation and nucleosome occupancy proﬁles between
normal and cancer cell line models of the breast and prostate. Here we describe the bioinformatic pipeline and
methods that we developed for the processing and analysis of the NOMe-seq data published by (Taberlay
et al., 2014 [1]) and deposited in the Gene Expression Omnibus with accession GSE57498.
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NOMe-seq-analysis.Experimental design, materials and methods
The NOMe-seq assay
The Nucleosome Occupancy and Methylation sequencing (NOMe-
seq) technique is an extension of whole genome bisulﬁte sequencing
(WGBS) enabling the simultaneous interrogation of nucleosome posi-
tioning and DNA methylation on the same strand of DNA [2]. This is
achieved through the treatment of isolated cell nuclei with theM.CviPI
GpC methyltransferase, which adds a GpC methylation “footprint” to
accessible regions of the genome. In contrast, endogenous mammalian
cytosine methylation occurs almost exclusively in CpG sites. Therefore,
accessibility dependent, M.CviPI added GpC methylation is separable
bioinformatically from endogenous methylation after WGBS by wheth-
er themethylcytosines occurwithin a CpG or GpC sequence context. Cy-
tosines in GpCpG sites are removed from the analysis as they are both a
CpG and GpC context, and therefore a mixture of endogenous methyla-
tion and accessibility. Additionally M.CviPI spuriously methylates
CpCpG sites at a low efﬁciency, so these sites are also discarded. Thisthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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sites available for nucleosome occupancy analysis and 20.4 million
WCG sites available for endogenous methylation analysis.Cell culture
Normal human prostate epithelial cells (PrEC), a prostate cancer cell
line (PC3), and a breast cancer cell line (MCF7) were obtained from the
American Type Culture Collection (ATCC). Normal human mammary
epithelial cells (HMEC) were obtained from Invitrogen. All cell lines
were cultured under recommended conditions at 37 °C and 5% CO2.HMEC
MCF7 PrEC
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Fig. 1. Venn diagram of overlap between nucleosome depleted regions found in the four
cell lines. Statistically signiﬁcant NDRs calls were obtained from the ‘ﬁndNDRs’ function
and overlaps between the cell lineswere plottedwith the ‘grangesVenn’ function in aaRon.Nucleosome occupancy and methylation sequencing (NOMe-seq)
Cells were trypsinized and centrifuged for 3 min at 500 g, then
washed in ice-cold PBS and resuspended in 1 mL ice-cold Nuclei Buffer
(10mMTris, pH 7.4, 10mMNaCl, 3 mMMgCl2, 0.1 mM EDTA, and 0.5%
NP-40, plus protease inhibitors) per 5 × 106 cells and incubated on ice
for 5 min. Nuclei were recovered by centrifugation at 900 g for 3 min
and washed in Nuclei Wash Buffer (10 mM Tris, pH 7.4, 10 mM NaCl,
3 mMMgCl2, and 0.1 mMEDTA containing protease inhibitors). Freshly
prepared nuclei (2× 106 cells)were resuspended in 1×M.CviPI reaction
buffer (NEB), then treated with 150 units ofM.CviPI (NEB; 50,000 units/
mL) for 15 min in 15 μL 10× reaction buffer, 45 μL 1 M sucrose, and
0.75 μL SAM in a volume of 150 μL. Reactions were quenched by the ad-
dition of an equal volume of Stop Solution (20 nM Tris – HCl [pH 7.9],
600mMNaCl, 1% SDS, 10mMEDTA, 400 μg/mL Proteinase K) and incu-
bated overnight at 55 °C. DNA was puriﬁed by phenol/chloroform
extraction and ethanol precipitation.
Libraries for genome-wide NOMe-seq analyses were then prepared
using the established protocols of the USC Epigenome Center. Brieﬂy,
genomic DNA (2 μg) was sonicated using a Covaris instrument to an
average fragment length of 150 bp. Achievement of the desired size
range was veriﬁed by Bioanalyzer analysis (Agilent Technologies).
Fragmented DNA was repaired to generate blunt ends using the END-
It kit (Epicentre Biotechnologies) according to the manufacturer's
instructions. Following incubation, the treated DNA was puriﬁed using
AMPure XP beads (Agencourt).Magnetic beadswere used for all nucleic
acid puriﬁcations in subsequent steps. Following end repair, A-tailing
was performed using the dA-tailing module according to the
manufacturer's instructions (New England Biolabs). Adapters with a 3′
“T” overhang were then ligated to the end-modiﬁed DNA. Modiﬁed
Illumina paired-end (PE) adapters were used. Ligation was carried out
using ultrapure, rapid T4 ligase (Enzymatics) according to the
manufacturer's instructions. The ﬁnal product was then puriﬁed with
magnetic beads to yield an adapter-ligation mix. Prior to bisulﬁte con-
version, bacteriophage lambda DNA that had been through the same li-
brary preparation protocol described above to generate adapter-ligation
mixes was combined with the genomic sample adapter ligation mix at
0.5% w/w. Adapter-ligation mixes were then bisulﬁte converted using
the Zymo DNA Methylation Gold kit (Zymo Research) according to the
manufacturer's recommendations. The ﬁnalmodiﬁed productwas puri-
ﬁed by magnetic beads and eluted in a ﬁnal volume of 20 μL. Ampliﬁca-
tion of one-half the adapter-ligated library was performed using
KapaHiFi-U Ready Mix under the following conditions: 98 °C for
2 min, followed by four cycles of 98 °C for 30 s, then 65 °C for 15 s and
72 °C for 1 min with a ﬁnal extension for 10 min in 50 μL total reaction
volume. The ﬁnal library product was examined on the Agilent
Bioanalyzer then quantiﬁed using the Kapa Biosystems Library Quanti-
ﬁcation kit according to the manufacturer's instructions. Optimal con-
centrations to obtain the correct cluster density were determined
empirically. Resulting libraries were plated using the Illumina cBot
and run on the Illumina HiSeq 2000 platform conﬁgured for 100 bp
paired-end reads according to the manufacturer's instructions.Data processing
Raw read pairs were aligned to the human genome (hg19) using
bwa-meth [3], a bisulﬁte aware wrapper for the bwa-mem aligner [4].
Read pairs with identical strand, start and end positions were considered
PCR duplicates and removed from downstream analysis using
MarkDuplicates from the Picard toolset (http://broadinstitute.github.io/
picard/). BisSNP [5] was then used to extract the methylation status of
allWCGandGCHsites in the genome for each cell line, and customscripts
(supplied in Supplementary Data 1) then used to tabulate the number of
cytosine (i.e. methylated) and thymine (i.e. unmethylated) containing
reads across each GCH and WCG in each cell line. These tables were
then imported into R for downstream analysis.
Detection of nucleosome depleted regions (NDRs)
A sliding window chi-squared test was used to detect regions of
statistically signiﬁcant increased GCH methylation compared to the
whole genome as a background, indicating a potential NDR. The number
of methylated (C) and unmethylated (T) counts at GCH sites with at
least 5× sequencing coverage was summed in 100 bp windows at
20 bp spacing. Each window was tested against the sum of Cs and Ts
of the whole genome, and windows were considered signiﬁcant when
their P-value is b10−15. Overlapping signiﬁcant windows are then
joined, and only returned as an NDR if at least 140 bp in size. This
procedure is implemented in the ‘ﬁndNDRs’ function of the aaRon R
package (http://github.com/astatham/aaRon) with user-tunable
parameters. Fig. 1 shows the number of NDRs found in each cell line
by ‘ﬁndNDRs’ using the default settings, that many of these NDRs over-
lap between the four cell lines and that a signiﬁcant number are also
unique to a single cell line.
Visualization of aggregate NOMe-seq proﬁles
To enable the visualization and comparison of NOMe-seq proﬁles
across sets of genomic regions (for example transcription start sites or
transcription factor binding sites) the ‘methylationPlotRegions’ family
of functions was implemented in aaRon. Fig. 2 shows average proﬁles
of both accessibility and DNA methylation surrounding transcription
start sites (TSSs) in MCF7 cells that do and do not overlap a H3K4me3
ChIP-seq peak, an active promoter chromatin mark. As expected, the
active, H3K4me3 marked TSSs show a distinct highly accessible region
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Fig. 2.MCF7 aggregate NOMe-seq proﬁles of the (a) accessibility and (b) CpG methylation levels surrounding transcription start sites split by the presence and absence of the H3K4me3
chromatin mark. UCSC knownGene TSSs were overlapped with ENCODEMCF7 H3K4me3 ChIP-seq peaks obtained using rtracklayer and AnnotationHub Bioconductor packages respectively.
NOMe-seq proﬁles of the H3K4me3 and unmarked TSSs were plotted against each other using the ‘methylationPlotRegions’ function in aaRon.
96 A.L. Statham et al. / Genomics Data 3 (2015) 94–96at the TSS with strongly phased nucleosomes downstreamwhereas the
inactive, unmarked TSSs are completely inaccessible (Fig. 2a). In
addition, DNA methylation is depleted in a multi-kilobase region
surrounding H3K4me3 marked TSSs, in contrast to the consistent high
methylation level across unmarked TSSs (Fig. 2b). Examples of other vi-
sualizations of NOMe-seq data using aaRon are included in Supplemen-
tary Data 1.
Discussion
Here we describe the bioinformatic pipeline and tools we have
developed for the analysis and visualization of NOMe-seq data for four
human cell lines [1]. The step-by-stepmanual supplied in Supplementa-
ry Data 1 enables other researchers to precisely reproduce and build
upon the analysis methods we have created, fostering advancement of
the epigenomics and bioinformatics ﬁelds as a whole.
Software availability
All software, the exact commands and custom scripts used for this
analysis have been documented in detail and are contained in
Supplementary Information 1 and are also available from https://github.
com/astatham/NOMe-seq-analysis. The ‘ﬁndNDRs’, ‘grangesVenn’,
‘methylationPlotRegion’ functions and others described in Supplementa-ry Information 1 are part of the aaRon R package available from http://
github.com/astatham/aaRon.
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